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Analysis of HLA class II genes in Japanese patients with
idiopathic membranous glomerulonephritis
SATORU OGAHARA, SETSUYA NAIT0, KASUMI ABE, ISAO MICHINAGA, and KIKuo ARAKAWA
Second Department of Internal Medicine, Fukuoka University School of Medicine, Fukuoka, Japan
Analysis of HLA class II genes in Japanese patients with idiopathic
membranous glomerulonephritis. Thirty unrelated Japanese adult pa-
tients with idiopathic membranous glomerulonephritis (1MG) and 50
unrelated Japanese normal controls were examined for HLA class II
genes. Both the 3.0 kb DQB and the 6.2 kb DQA restriction fragments
were simultaneously identified in 86.7% of the patients. These were
significantly different from the 14% frequency of the fragments in
controls (relative risk = 39.9; P = 1.7 x l0°). The haplotype
DR2-DQw1 associated with 1MG seemed to be Dw2 which was essen-
tially different from the haplotype common to the normal Japanese
population, Dw12, This was because most of the restriction fragment
length polymorphism (RFLP) of DQB and DQA of the patients coin-
cided with that of homozygous cell lines with Dw2. The DRB probe
showed no significant differences in the hybridization patterns between
the patient group and HLA-matched controls. These findings indicate
that the specific HLA-DQ polymorphism correlates primarily with
Japanese 1MG.
different between Japanese and Caucasians, specifically HLA-
DR2-DQwl and DR3-DQw2 [7, 81, respectively.
In the present study, we attempted to ascertain the HLA
regions much more specifically associated with 1MG by exam-
ining the restriction fragment length polymorphisms (RFLP) of
HLA class II genes. We also tried to determine the DQA area
of HLA class II genes associated with 1MG using the polymer-
ase chain reaction (PCR) method, since Saiki et al established it
for HLA DQA typing with sequence-specific oligonucleotide
probes using the PCR technique [9]. We compared the pub-
lished amino acid sequences of second exon of HLA class II
genes related with Japanese and Caucasian 1MG.
Methods
Patients, controls and cell lines
Specific HLA class II alloantigens, HLA-DR2 and -DQw1,
have been found in Japanese patients with idiopathic membra-
nous glomerulonephritis (1MG) about eight times more fre-
quently than in the normal Japanese population [1—3]. Since
HLA-DR2 and DQw 1 were very closely linked to each other
[4], the association of HLA-DR2 and -DQw1 with 1MG was
considered to be due to that of a haplotype of HLA-DR2-DQwl
with 1MG, However, the association clarified by serologically
typed HLA was too rough to define the "host factors for
susceptibility" to 1MG.
HLA-DR and -DQ regions were subdivided according to
specificities which were characterized by mixed lymphocyte
culture. Recent advances in DNA technology have made it
possible to define almost HLA-D clusters [5] and HLA class II
gene sequences [6], and depict some DNA sequences of HLA
class II genes being responsible for the susceptibility of diseases
like insulin-dependent diabetes mellitus (IDDM) and rheuma-
toid arthritis (RA) from the serological association of HLA with
those diseases. The haplotype of HLA-DR2-DQw1 has also
been known to be one of the most common among Japanese,
and is able to be divided into at least four distinct HLA-D
clusters. Furthermore, the haplotype associated with 1MG is
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Thirty unrelated Japanese patients were diagnosed as having
1MG clinically and by renal biopsy, and then were determined
of their HLA phenotype. At the time of renal biopsy, their mean
age was 56.0 12.1 years. Ten patients were male and 20 were
female. Fifty normal persons were chosen as random unrelated
Japanese controls and 24 individuals with HLA-DR2 were used
as HLA-DR-matched controls. Epstein-Barr virus-transformed
B-lymphoblastoid cell lines which were homozygous for HLA-
DR2 were used to produce contrast electrophoretic pictures.
The D02089l5, WT8, SHCU and MGAR cell lines as Dw2,
the E4181324 cell as Dwl2, the KASO1I as Dw21 cell line, and
the RML as Dw22 were obtained from the Tenth International
HLA Workshop core cell lines.
Serological HLA typing
HLA-A, -B, -C, -DR and -DQ typings were done by the
standard microdroplet lymphocytotoxicity test, using antisera
from the Tenth International HLA Workshop, Japanese re-
gional antisera and the local antisera comparable to them.
Restriction fragment length polymorphism analysis (RFLP)
The analysis procedure was performed according to the
standardized Southern blot workshop technique established at
the Tenth International HLA Workshop [10]. In brief, genomic
DNA samples were obtained by phenolchloroform extraction of
sodium dodecyl sulfate (SDS) and by lysing cells with protein-
ase K from peripheral blood leukocytes of patients, controls
and the cell lines. The probes used for hybridization were 0.78
kb DRB, 1.2 kb DQB and the 1.6 kb DQA cDNA clone,
provided from the Tenth International HLA Workshop [5]. The
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DOA1 *0101 DHVASCGVNLYQFYGPSGQYTHEFDGDEEFYVDLERKETAWRWPEFSKFGGFDPQGALRNMAVAKHNLNIMIKRYNSTAATN
0102 Q
0103 F - K
0201 Y S F V-KL—L—HRLR ————F——T—I——L L———S
0301 Y S S V—QL—L—RR—RR————F——T—I——L V———S
0401 Y S Q G———-V—CL—VLRQ—R —-——F——T—I——L SL———S
0501 Y S Q G-———V—CL—VLRQ—R ————F——T—I——T L———S
0601 S F Q G————V-CL-VLRQ—R ————F——T—I——T L———S
Note, aa, amino acid position; , positive spot
GH27
Fig. 1. A. Comparison of amino acid sequences of DQA. The PCR primers (GH26, GH27) and their relationship to the DQA genes are indicated
by arrows. B. The sequence of allele-specific oligonucteotide probes and their specificity.
restriction endonuclease, Taq I (Toyobo Co. Ltd., Tokyo) were
used to digest the genomic DNA. Ten g of the endonuclease-
digested DNAs were subjected to electrophoresis on 0.7%
agarose gel for 40 hours at 35 volts in 40 mvt Tris-HC1, 20 mM
glacial acetic acid and 2 mM EDTA (TAE buffer) [5]. The gel
was soaked in 0.15 M HCI for ten minutes, and then soaked in
0.4 N NaOH for 30 minutes. The gel was transferred onto a
nylon membrane (Gene Screen Plus, NEN, Massachusetts,
USA) by the method of Southern [11]. DNAs were transferred
overnight with 0.4 N NaOH solution as transfer buffer, The
probes were labeled with [a-32P] dCTP by the multiprime
labeling method [121. The membranes were prehybridized over-
night in prehybndization mix (50% deionized formamide, 0.1%
Denhardt solution [13], 5x SSPE (30x SSPE is 5.4 M NaC1, 0.3
M NaH2PO4 and 30 mst EDTA), 0.1% SDS, 5% Dextran sulfate
and 100 tg/m1 Herring sperm denatured DNA) at 42°C with
agitation. The membranes were hybridized in prehybridization
mix with labeled probes for 48 hours at 42°C. The membranes
were washed with 2 x SSPE twice for five minutes at room
temperature, and with 2x SSPE and 0.5% SDS once for 15
minutes at 65°C, and then with 0.5x SSPE for 15 minutes at
65°C. The membranes were subsequently dried and exposed to
an X-OMAT-AR film (Kodak, Rochester, New York, USA)
from overnight to seven days at —80°C.
Amp1ficarion of genoinic DNA
The second exon of the DQA gene was amplified from
genomic DNA with the use of PCR. The PCR primers used
were GH26 and GH27 as described [14] (Fig. lA). DNAs were
prepared from a part of the RFLP analysis samples. One g of
genomic DNA was amplified by PCR. Two units of Taq
polymerase (Stratagene, CA) were added to a 100 1.d volume of
polymerase buffer containing 10 mrvi Tris-HC1 pH 8.4, 50 mM
KCI, 2.5 mr't MgCl2 and 100 g/ml gelatin, overlaid with mineral
oil. The reaction was adjusted to 200 M for each of the four
deoxynucleoside triphosphates and 0.2 /LM for each of the PCR
primer pairs, amplified by using a programmable thermal cycler
(Perkin Elmer-Cetus Co., Norwalk, Connecticut, USA). Each
cycle consisted of a 30 second denaturation step at 95°C, a 55°C
annealing step, and a two minute extension step at 72°C except
for initial denaturation for five minutes at 95°C, and a final seven
minute extension step at 72°C. The PCR products were con-
firmed by the electrophoresis in a 1.5% agarose gel.
Dot typing of PCR DQA products
Ten sequence-specific oligonucleotide (SSO) probes were
designed and supplied by the Tenth Japan HLA Workshop (Fig.
IB). Thirty to 50 ng of specific PCR products was spotted onto
--n-
B
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GH26
DQA1 Specificity
5' Sequence 3' aa 0101 01020103 0201 03010401 0501 0601
1 CACGTAGAACTCCTCATC 32-37 *
2 CACGTAGAACTGCTCATC 32-37
3 CTCCTTCCTCTCCAGGTC 38-43 *
4 GTCTCCTTCTTCTCCAGG 39-44
5 CAGAGGCAACTTCCAGAC 45-50
6 ATCTTCTAAATCTGCGGA 51-56
7 TCAGACTGTTCAAGTTAT 71-7 6
8 CGTAGAACTGCTCGTCTC 31-36
9 TCATGGGTGTACTGGCCA 23-28
10 TCATGGGTGAACTGGCCA 23-28
* *
* * *
*
*
*
* *
* *
*
*
* *
* *
*
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Table 1. HLA-A, B, DR, DQ type, RFLP of DQB and DQAI genes and subregion of DQAI of patients with 1MG
No. Patient
HLA-
RFLP
DQB DQA1 DOT
3.0 kb 6.2 kb 7.0 kb DQA1A B DR DQ
I
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
M. MOR.
T.YAM.
M. MIZ.
T. ISH.
M. FUJ.
A. HAS.
H. MAE.
K. FUJ.
M. HIR.
K. KIM.
Y. ARA.
A. HIG.
N. MAS.
T. KUS.
T. TOK.
S. MIT.
H. YOS.
T. TAN.
S. MIY.
T. 00K.
K. YOS.
5. 00K.
S. OOT.
K. 00K.
U. KUM.
T. TIK.
T. TAK.
H. SAl.
M. NAK.
K. KUM.
2
24
2
11
24
24
2
2
26
2
24
11
24
24
24
11
31
2
2
24
24
26
2
24
2
24
2
2
2
11
11
31
24
24
26
31
11
24
24
26
31
26
26
24
26
26
31
11
26
33
33
31
31
31
24
60
7
39
51
7
51
54
13
62
35
7
61
54
52
51
35
35
52
39
48
7
35
35
7
44
44
7
62
35
54
61 2
51 2
56 2
60 2
35 2
52 2
2
60 2
2
54 2
52 2
62 2
62 2
35 2
60 2
48 2
39 2
2
55 2
55 2
60 2
51 2
39 2
35 2
61 13
60 13
51 1
4
59 4
59 4
8 1
1 1
8 1
8 1
1 1
1
4 1
12 1
1
4 1
9 1
4 1
5 1
1
8 1
8 1
8 1
1
9 1
14 1
1 1
8 1
1 1
1
12 1
4 1
9 1
11 7
12 7
4
4
7
3
3
3
3
7
3
+
+
+
+
+
+
+
+
+
--
+
+
+
+
+
4-
+
--
+
+
+
+
+
+
+
+
—
—
—
—
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
--
+
+
—
—
—
—
—
—
+
+
—
+
—
—
—
—
—
—
—
+
—
—
—
+
—
—
—
—
—
—
—
—
—
—
—
—
0102
0102
0102
0102
0102
0102
0102
0102
0102
0102
0102
0102
0102
0102
0102
0102
0102
0102
0102
0102
0102
0102
0102
0102
0102
0102
0101
0401
0401
0301
0103
0101
0103
0103
0101
0103
0301
0401
0301
0301
0301
0103
0301
0103
0301
0101
0101
0103
0101
0401
0301
0301
a , existent; —, not existent
nylon membranes, which were presoaked in soaking solution
[0.15 M NaC1, 10 m sodium phosphate, 1 mrsi EDTA (pH 7.4)]
for 15 minutes, and then dried at 60°C. Membranes were
rewetted with 0.4 N NaOH for one minute for denaturation, and
then soaked in a soaking solution for five minutes, and exposed
to UV light to fix the PCR products for 30 seconds. SSO probes
were phosphorylated at their 5'- termini with [y-32P] ATP and
T4 polynucleotide kinase (TOYOBO, Osaka, Japan). Mem-
branes were prehybridized in a hybridization solution (50 mM
Tris-HCI pH 8.0), 3M tetramethylammonium chloride [151, 2
mM EDTA (pH 8.0), 5x Denhardt's solution [13], 0.1% SDS
and 100 j.tg/ml denaturated Herring sperm DNA) for one hour at
54°C. Hybridization with 32P-labeled SSO probes was accom-
plished by the addition of a 2 pmol SSO probe in 5 ml of the
hybridization solution for one hour at 54°C. The membranes
were rinsed twice in 0.3 M NaCI, 20 m sodium phosphate, 2
mM EDTA, and 0.1% SDS for 10 minutes at room temperature,
washed in 50 m Tris-HC1 (pH 8.0), 3 M tetramethylammonium
chloride, 2 mt EDTA and 0.1% SDS for 10 minutes at room
temperature and then for 30 minutes at 58°C, and exposed for
autoradiography with an intensifying screen for one hour.
Statistical analysis
Statistical analysis was performed by the chi-square method
and Fisher's exact test. P values were multiplied by the number
of antigens and fragments tested (corrected P) [16]. Odds ratios
were calculated with the use of the formula (a x d)/(b X c) and
by convention were expressed as relative risks. When one
element of the equation was zero, the relative risk was calcu-
lated with the formula of Haldane [17]:
[(a + 112)(d + 1/2)]
[(b + 1/2)(c + l/2)f
Results
Table 1 lists HLA-A, B, DR and DQ antigens typed serolog-
ically, existence of the specific DQB and DQA RFLP, and DQA
subtypes by dot typing of the 30 Japanese patients with 1MG.
Hybridization with a DQB probe of genomic DNA digested
with Taq I showed two constants (3.4 and 4.5 kb) and at least
two polymorphic bands (3.0 and 5.3 kb). Hybridization with a
DQA probe of genomic DNA digested with Taq I showed at
least five polymorphic DQA1 bands (2.8, 4.6, 5.5, 6.2 and 7.0
kb) and two polymorphic DQA2 bands (2.3 and 2.0 kb). These
hybridization patterns were consistent with those described by
Marcadet et a! [181 and Bontrop et a! [19].
Table 2 presents the antigen phenotypic frequencies of pa-
tients and controls with HLA-DR2, -DRw53 and -DQw1, and
the frequencies of patients and controls with the Taq I-digested
3.0 kb DQB and 6.2 kb DQA restriction fragments. Both of
these fragments were simultaneously identified in 86.7% (26 of
30) of patients. This percentage was significantly different from
the 14% (7 of 50) frequency of the fragments between patients
and controls identified in controls. The relative risk of these
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Table 2. Comparison of frequencies of HLA serological class II typing and fragments of DQB and DQA RFLP
Patients
= 30)
Controls
(N = 50)
Relative
risk P
Corrected
P value
Serology DR2
DRwS3
DQw1
RFLP DQB 3.0 kb
DQA 6.2 kb
80.0%
36.7%
90.0%
86.7%
86.7%
30.0%
60.0%
58.0%
14.0%
14.0%
9.3
0.4
6.5
39.9
39.9
1.5
2.5
1.7
1.7
X
0.04
x iO
x io'°
x 10—0
1.8 x iO
NS
0.013
1.7 x iO—
1.7 x lO
Fig. 2. Electrophoretic patterns of Taq I-
digested DNAs from homozygous cell lines
hybridized with (A) DQB and (B) DQA
probes.
fragments were much higher than those of DR2 or DQwI (39.9
vs. 9.3 or 6.5), and the statistical differences were much more
significant in the fragments than serologically typed antigens,
DR2 and/or DQw1 (1.7 x 10_b vs. 1.5 x l0 or 2.5 x 10).
Figure 2A shows that electrophoresis of genomic DNA of
each homozygous cell lines digested with Taq I produced four
restriction fragment patterns when hybridized with the DQB
probe. The 4.5 and 3.4 kb fragments were observed in all cell
lines. The 3.0 kb fragment was observed in all cell lines with
Dw2, but was not found in the cell lines with Dwl2, 21 and 22.
The 0.9 kb fragment was found in only the cell lines with Dw22.
The 5.3 kb fragment was found in only the cell line with Dw21.
The cell line with Dw12 did not have 3.0, 0.9 or 5.3 kb
fragments.
Since the number of fragments hybridized with DQA was less
than that of DQB, the polymorphisms of DQA fragments were
easily definable. Figure 2B shows that the electrophoresis of
genomic DNA of each homozygous cell lines digested with Taq
I produced three restriction fragment patterns when hybridized
with the DQA probe. The 6.2 kb fragment was found in all cell
lines with Dw2 and Dw2 1. The 4.4 kb fragment was found only
in Dw22. The 7.0 kb fragment was found only in Dwl2.
Twenty-four Japanese adult patients with 1MG and a haplo-
type of HLA-DR2-DQw 1 (DR2-patients) and twenty-four Jap-
anese normal controls with the same haplotype (HLA-matched
controls) were examined. Figure 3 presents the electrophoretic
patterns of Taq I-digested DNAs from a portion of the patients
and HLA-matched controls hybridized with DQB probes. All
DR2-patients had the 3.0 kb fragment. This fragment was found
in only three out of 24 HLA-matched controls (RR 301; P =
1.0 x 10).
Figure 4 illustrates the electrophoretic patterns of Taq I-di-
gested DNAs from a portion of the DR2-patients and HLA-
matched controls hybridized with DQA probes. The 6.2 kb
fragment was also found in all DR2-patients. In contrast, this
fragment was found in only 12.5% of the HLA-matched con-
trols (RR 301; P = 1.0 x l0—). The 7.0 kb fragment was
found in 25% of the DR2-patients, but was found in 88% of the
HLA-matched controls (RR = 0.04; P = 3.7 x 10—s).
NS, not significant.
A
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Fig. 3. Electrophoretic patterns of Taq I-
digested DNAs from a portion of (A) patients
with 1MG and (B) normal controls hybridized
with DQB probes.
Fig. 4. Electrophoretic patterns of Taq 1-
digested DNAs from a portion of (A) patients
with 1MG and (B) normal controls hybridized
with DQA probes.
Fig. 5. Electrophoretic patterns of Taq I-
digested DNAs from a portion of (A) patients
with 1MG and (B) normal controls hybridized
with DRB probes.
Figure 5 illustrates the electrophoretic patterns of Taq I-di-
gested DNAs from a portion of the DR2-patients and HLA-
matched controls hybridized with DRB probes. The DRB probe
gave similar electrophoretic patterns between the patient group
and the controls. The 1.4 kb fragment was found in all DR2
patients and HLA-matched controls.
The DQA subregion of all patients with 1MG was determined
by DQA dot typing. Twenty-six patients were assigned to have
DQA1*0102, six patients, DQA1*010l, seven patients,
DQA1 *0103, nine patients, DQA 1*0301, and four patients,
DQA 1*0401. However, none of the patients were assigned to
have DQA1*0201, DQA1*050l or DQA1*0601 (Table 1).
Discussion
The present study suggests the existence of a strong associ-
ation between Japanese 1MG and some specific fragments of
RFLP in DQ. The allele was represented by the 3.0 kb fragment
of DQB RFLP and the 6.2 kb of DQA RFLP. Since these
fragments were thought to correspond to the HLA-Dw2 haplo-
type when they were compared to the patterns of RFLP of
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HTCs with DR2 related D type, Dw2, Dw12, Dw2l and Dw22,
86.7% of patients and 12.5% of the normal controls were
suggested to have Dw2. Most of the controls with HLA-DR2
probably had Dw12 as seen in a report on the normal Japanese
population [201.
On the other hand, the patterns of DRB RFLP digested with
Taq I were very similar between patients with DR2 and HLA-
matched controls. RFLP of DRB was clarified by using a
variety of restriction enzymes such as BamH I, Bgl II, EcoR I,
EcoR V, Hinc II, Hind III, Kpn I, Msp I, Pst I, Pvu II, Sst I and
Taq I at the Tenth HLA International HLA Workshop [211.
However, there were few fragments distinguishing between
Dw2 and Dw12.
The present study revealed that patients with 1MG commonly
have a relatively less frequent DR2-positive haplotype assigned
to Dw2 in the Japanese population in contrast to the Bw52-DR2
assigned to Dw12 more frequently found in the same population
[22]. Two of six patients without DR2 also had both the DQB
3.0 kb and DQA 6.2 kb fragments. These patients (patients No.
25 and 26) were typed as HLA-DRw13. Although DRw13 was
less frequent in patients because of the much more frequent
occurrence of DR2, the possibility exists that DRw13 might be
associated with the susceptibility to 1MG. This is because
DRwl3 has a linkage disequilibrium with DQw1, and the
frequency of DQw1 was higher than that of DR2 in the patients.
Patients with DQA1*0102 simultaneously exhibited both frag-
ments of 3.0 kb DQB and 6.2 kb DQA, while patients with
DQA1*0103 had fragments of 7.0 kb DQA except for patients
No. 1 and 22. It is known that DQA1*0102 was in strong linkage
disequilibrium with DR2(Dw2)-DQw6, DR2(Dw21)-DQw5 and
DRw13(Dw19)-DQw6, whereas the DQA1*0l03 was in strong
linkage disequilibrium with DRwl3 (Dw18)-DQw6, DR2
(Dw12)-DQw6 and DRw8-DQwI [23]. These results thus sup-
port the fact that patients with DQA1*0102 had DR2 (Dw2) or
DRw13 (Dw19). DQA dot typing clearly confirmed that some
patients with the serologically homozygous gene of DQ (No. 6,
14 and 18) were able to be assigned as a heterozygote.
In Caucasians, there are HLA-B genes in the strong linkage
disequilibrium with HLA-DR3 forming two haplotypes, that is,
HLA-B8-DR3 and HLA-B18-DR3. Sacks et al reported that
B8-linked DR3 is different from B 18-linked DR3 from the
analysis of the DRB genes by RFLP, biochemical studies of DR
molecules by two-dimensional gel electrophoresis and func-
tional studies of mixed lymphocyte reactions [24]. Caucasian
patients with 1MG have been reported to be associated with a
haplotype of HLA B8-DR3 [25—27]. It is interesting to note that
a HLA-DR2 subtype in Japanese and that of HLA-DR3 in
Caucasians were associated with susceptibility to 1MG. HLA-
B8, B18 or DR3 are very rare in Japanese. Thus, no disease
associated with these antigens has been reported in Japanese.
The possibility may exist that the HLA-DR2 (Dw2)-DQw1
haplotype in Japanese and HLA-B8-DR3 in Caucasians possess
a similar unknown gene susceptible to 1MG in linkage disequi-
librium specific to races. This would mean that the common
host factors to 1MG might be existent in HLA-DR2 (Dw2) in
Japanese and HLA-B8-DR3 in Caucasians.
Since the DRA gene is invariant in structure except for the
cytoplasmic portion, allelic polymorphism in the DR subregion
is found only in the DRB gene and most of the allelic variability
is localized to the first domain of the DRB gene. Unlike the DR
gene, polymorphism in the DQ gene is found both in DQA and
DQB. Todd, Bell and McDevitt reported that the specific amino
acid residue of DQ molecules could confer the resistance to
IDDM [28], and Gregersen, Silver and Winchester reported that
specific amino acid residues of DR molecules could confer the
susceptibility to RA [29]. Therefore, it may be possible to point
out common amino acid residues of class II molecules which
showed a strong association with 1MG in Japanese and also in
Caucasians. The published amino acid sequence of the second
exon at the DQA1, DQB1, DRB1 DRB3, and DRB5 genes
coding HLA-DR2, DR3, DQw1 and DQw2 antigens were com-
pared with each other [30]. There was no existence of a
common specific sequence in DQA1*0102 and DQA1*0401
genes, in DQB*0602 and DQB1*0201 genes, and in DRB1*1501
and DRB 1*0301 genes, respectively. The DRB 1*0102 gene
indicated a strong linkage disequilibrium with the DRB5*0l01
gene, and the DRB1*0301 gene with the DRB3*0101 gene,
respectively. When the amino acid sequence of the DRB5*010l
gene was compared with that of the DRB3*0101 gene, both
genes were found to have leucine at position 38. It was known
that the DRB 1 *1201 genes also had leucine at the same position.
Almost all other DRB3 or B5 genes have valine or alanine at
position 38. Residue 38 of the first domain of the DRB gene was
included in the second hypervariable region (residues 25-38).
According to the predicted structure of class II molecules [311,
this region is located in the base of the cleft formed by the
extracellular domain of class II molecules. If allelic polymor-
phisms in the second hypervariable region determine the func-
tional effects on the antigen binding and on the T cell recogni-
tion, these polymorphisms might confer the susceptibility to
1MG. Since these sequences were from the literature, it is
essential to sequence the class II genes from Japanese and
Caucasian patients with 1MG if common factors exist between
HLA-DR2 (Dw2) in Japanese and HLA-DR3 in Caucasians.
Also important is whether or not these genes may have a
linkage disequilibrium with common susceptible genes of 1MG.
Some diseases have been reported to be associated with the
HLA-Dw2 haplotype. Honda et al first reported that all Japa-
nese patients with narcolepsy had HLA-DR2 [32]. Inoko et al
demonstrated the 100% presence of the DQB EcoR I 2.4 kb,
BamH I 2.9 kb, and Pst 112 kb fragments in narcolepsy [33].
Matsuki et al described the differences between Dw2 and Dw12
using Taq I-generated DQB RFLP and reported that all patients
with narcolepsy had Dw2 [34]. Unlike 1MG, Caucasian patients
with narcolepsy also have Dw2. Jacobson et al reported that the
RFLP proffle of HLA DR2 (Dw2) is found in Caucasian patients
with multiple sclerosis (MS) [35]. In contrast, Naito, Tabira and
Kuroiwa reported that there was no significant association with
HLA in Japanese patients with MS [36]. Although it is unclear
whether or not racial heterogeneities exist among these dis-
eases, 1MG might be a good model for revealing the host factors
of susceptibility to diseases.
In conclusion, there may be a definite association between a
specific DQ gene and Japanese patients with 1MG. Two hypoth-
eses are proposed. One is the existence of some specific HLA
class II genes actually in the part of the pathogenesis of 1MG.
The other is the existence of unknown disease-susceptible
genes in a linkage disequilibrium with HLA class II genes.
There might be two ways to clarify these two possibilities. One
is to ascertain the whale DNA sequences of the HLA class II
area in Japanese and Caucasian patients with 1MG and compare
them. The other is to find some common gene sequences
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between the patients with 1MG with associated HLA haplotype
and rare ones without the associated HLA haplotype.
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